Acorda In The News

January 2015 – Mad Money with Jim Cramer

September 2014 - The RPM Report

Ron Cohen, M.D. Op-Ed: To Curb Medical Costs, Let Market Forces Do their Job

November/December 2014 - PharmaVOICE

Year in Preview: 2015 featuring commentary from Mike Russo, head of Acorda’s Digital team

November 2014 - Baseline Magazine

Acorda: Taking a Therapeutic Approach to Collaboration

October 2014 - Investor's Business Daily

Civitas Acquisition: Q&A with Ron Cohen, M.D.

October 2014 - Westchester Magazine

Westchester’s Biotech Industry

October 2014 – Mad Money with Jim Cramer

September 2014 - Westchester County Business Journal

Acorda to Acquire Civitas Therapeutics

September 2014 - IR Magazine

Latest NIRI interns get to grips with IR

September 2014 – HR Executive

Lessons from Recruiting in Pharma

July 2014 – Forbes

Can Anything Stop Drug Companies From Fleeing The U.S. Tax System?

July 2014 – Squawk Box

CEO Dr. Ron Cohen on Squawk Box

April 2014 – Fox Business Network

CEO Ron Cohen: Investing in Biotech

March 2014 – Xconomy

10 Takeaways From New York’s Life Science Disruptors

January 2014 – Bloomberg News

M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals

January 2014 – Forefront Magazine

Lab Tests for Your Legal Department

December 2013 – Westchester County Business Journal

Creating the Next Generation of Leaders in Scientific Research

December 2013 – PM360

Recruiting and Retaining the Best Talent

November 2013 - Latin Business Today

The High Tech Brain Gain And STEM

November 2013 - 914Inc.

Acorda’s Jane Wasman Featured in 914Inc.’s Annual “Women in Business” Issue

November 2013 – Mad Money with Jim Cramer

October 2013 - The Rivertowns Enterprise

Acorda and WFAS Team Up on High School Science Award

October 2013 – Fox Business Network

Acorda CEO: Impact of the Affordable Care Act

October 2013 - The Deal Pipeline

Intended consequences

October 2013 - PharmaVOICE

Mentoring: Effective Programs Yield Successful Employees

July 2013 – Pharmaceutical Executive

Pharma Exec’s 2013 Emerging Pharma Leaders

July 2013 – PM360

Optimizing the Client-Agency Relationship

July 2013 – Genetic Engineering & Biotechnology News

HTRF Applications in New Drug Discovery

June 2013 – Mashable

One Man’s Mission to Map More Accessible Cities

June 2013 – Brain Blogger

Promoting Remyelination in Multiple Sclerosis – an Interview on rHIgM22

June 2013 – The RPM Report

Medicare’s Independent Payment Advisory Board: First, Do No Harm

May 2013 – NYC Tech Connect

Interview with Dr. Ron Cohen, Founder, President and CEO of Acorda Therapeutics, Inc.

May 2013 – Genetic Engineering & Biotechnology News

Pharma Builds Bridges with Advocacy Groups

May 2013 – Corporate Counsel

Best Legal Departments 2013 - Acorda Therapeutics: Scrappy But Savvy

April 2013 – Mad Money with Jim Cramer

Acorda CEO: Ampyra Helping Stroke Victims Walk Better

January 2013 – Forbes

How The U.S. Can Attract Biotech Firms by Imitating China

October 2012 – Nature Medicine

Early-stage therapies target surgery-induced erectile dysfunction

September 2012 – Pharmaceutical Executive

Upgrading the Tax Code to Bolster Biotech

June 2012 – TechReview

Pill could reverse effects of a stroke long after it hits.

March 2012 – Pharmaceutical Executive

FDA’s Necessary Dose of Reality

July 2011 – Xconomy

Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline

May 2011 – The Scientist

Best Places to Work in Industry, 2011

March 2011 – Life Science Leader

When Your Science Leads to an Unexpected Business Opportunity

February 2011 – 914Inc.

Westchester’s MedMen: The Classmates-Turned-Competitors Behind the County’s Biotech Boom

November 2010 – InVivo

Launching Acorda’s AMPYRA:The Long Road to Approval